Application of E ring iodine substituted silybin to preparing glycosidase inhibitors

A technology of silibinin esters and uses, which is applied in the field of drug use of E ring iodine to replace silibinin for the preparation of glycosidase inhibitors, can solve the problems of diabetes without glycosidase inhibition, and achieve a clear industrialization prospect , strong inhibition of α-glucosidase, beneficial to the effect of energy saving and emission reduction

Inactive Publication Date: 2011-04-06
DALI UNIV
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But it is obvious: the above studies have only focused on the antioxidant and cytoprotective effects of silybin flavonoid lignans
[0007] Although the flavonoid lignan compound

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0023] Example 1: Compound of formula (1) (±)-2-[2,3-dihydro-3-(3-iodo-4-hydroxy-5-methoxyphenyl)-2-hydroxymethyl-1,4-benzene Preparation of dioxane-6-]-2,3-dihydro-3,5,7-trihydroxy-4H-1-benzopyran-4-one

[0024] 1.1 Instruments and reagents:

[0025] UV spectra were measured with a Shimadzu UV-240 UV spectrophotometer; 1H NMR spectroscopy 1 H-NMR was determined by INOVA type superconducting nuclear magnetic resonance spectrometer (VARIAN INOVA-400MHz) (tetramethylsilyl ether TMS as internal standard); electrospray mass spectrometry ESI-MS was determined by BrukerEsquire 3000+ mass spectrometer, and silica gel was used for column chromatography (100-200, 200-300 and 300-400 mesh) and silica gel GF254 (10-40 mesh) for thin layer chromatography are produced by Qingdao Ocean Chemical Factory; all reagents used are of analytical grade; thin layer chromatography (PTLC) ) with the aluminum foil silica gel plate of Merck company; Sephadex LH-20 for column chromatography adopts the pr

Example Embodiment

[0033] Example 2 : Compound (1)(±)-2-[2,3-dihydro-3-(3-iodo-4-hydroxy-5-methoxyphenyl)-2-hydroxymethyl-1,4-benzene Determination of Inhibitory Activity of Dioxane-6-]-2,3-dihydro-3,5,7-trihydroxy-4H-1-benzopyran-4-one on α-glucosidase

[0034] 2.1 Instruments and Reagents

[0035] 2.1.1 Experimental instrument

[0036] Microplate reader: ELISA plate reader (Bio-Tek Instruments, USA)

[0037] 2.1.2 Reagents

[0038] α-glucosidase, α-D-glucosidase (Sigma, 500U / ml); 4-nitrophenol-α-D-glucopyranoside (PNPG, Merck), reduced glutathione (Shanghai Shenggong) , Acarbose is Baitangping (Bayer Health Care Co., Ltd., Beijing).

[0039] 2.2 Test method

[0040] The inhibitory effect of compounds on α-glucosidase was determined by colorimetric method: phosphate buffer (67 mmol / L, pH 6.8, 170 μL) was added to the sample well, reduced glutathione (1 mg / mL, 5 μl), α-D-glucosidase (diluted to 0.2 U / ml with phosphate buffer, 25 μl), compound (1) was dissolved in dimethyl sulfoxide, d

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to application of E ring iodine substituted silybin to preparing glycosidase inhibitors and in particular discloses application of E ring iodine substituted silybin ester-type flavonolignans or pharmaceutical salt thereof to preparing drugs for inhibiting alpha-glycosidase and preventing and treating type II diabetes. The flavonolignans has extremely obvious activity for inhibiting alpha-glycosidase and the intensity of activity of the 40mcg/ml flavonolignans for inhibiting alpha-glycosidase reaches 64.1%. The measured half-inhibitory concentration of the flavonolignans shows that the intensity of activity of the flavonolignans for inhibiting alpha-glycosidase is 35 times that of the positive control drug acarbose. The pharmacodynamics result shows that the flavonolignans or pharmaceutical salt thereof can be expected to be applied to preparing glycosidase inhibitors, especially the drugs for preventing and treating type II diabetes.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner DALI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products